- Home
- LXRX vs ANGO Comparison
LXRX vs ANGO Comparison
Compare LXRX & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LXRX | ANGO |
|---|---|---|
| Founded | 1995 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 547.4M | 439.8M |
| IPO Year | 2000 | 2004 |
Fundamental Metrics
Financial Performance| Metric | LXRX | ANGO |
|---|---|---|
| Price | $1.66 | $11.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.15 | ★ $19.33 |
| AVG Volume (30 Days) | ★ 2.4M | 252.4K |
| Earning Date | 03-05-2026 | 04-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 77.78 | ★ 81.92 |
| EPS | ★ N/A | N/A |
| Revenue | $49,803,000.00 | ★ $291,010,000.00 |
| Revenue This Year | N/A | $9.11 |
| Revenue Next Year | N/A | $4.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 60.24 | 10.17 |
| 52 Week Low | $0.33 | $8.36 |
| 52 Week High | $1.83 | $13.99 |
Technical Indicators
Market Signals| Indicator | LXRX | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 55.24 | 57.06 |
| Support Level | $1.08 | $10.40 |
| Resistance Level | $1.81 | $11.74 |
| Average True Range (ATR) | 0.11 | 0.36 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 50.91 | 91.92 |
Price Performance
Historical ComparisonAbout LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.